ITGA2 and pancreatic intraductal papillary-mucinous neoplasm: Although an in vivo experiment was not performed, our results support the conclusions of this study on SDC1 and ITGA2. We believe that SDC1 and ITGA2 may also be biomarkers for detecting the conversion of IPMN to PDAC, which warrants further study.